BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Podcast

  Q3 Earnings Are Here, Novo Ditches Cell Therapy but Buys Akero, Gov’t Shutdown Hits CDC

  Johnson & Johnson has yet to make a drug pricing deal with Trump; Novo makes more moves under new CEO; more than 1,000 laid off from CDC, though many immediately hired back; the BIOSECURE Act is back and more.

  October 15, 2025

   · 

  1 min read

   · 

  Heather McKenzie
• 

  Gene therapy

  FDA’s Second Platform Designation Goes to Krystal After Sarepta Withdrawal

  After the FDA revoked Sarepta Therapeutics’ platform designation in July, Krystal Biotech is “poised to be the first major beneficiary” of this program, according to analysts at William Blair.

  October 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Mergers & acquisitions

  BioCryst Snaps Up Fellow Angiodema Player Astria for $700M

  The acquisition will give BioCryst an investigational injectable drug for hereditary angioedema, potentially complementing its FDA-approved oral drug Orladeyo.

  October 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  ALS

  BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line

  Bristol Myers Squibb and insitro first partnered in 2020 to develop induced pluripotent stem cell models of amyotrophic lateral sclerosis and frontotemporal dementia. Last December, BMS exercised its option for an ALS target.

  October 15, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• Press Releases

  PolyActiva to Present Advancements in Next-Generation Ocular Micro-Implant Technology at Eyecelerator® @ AAO 2025

  October 15, 2025

   · 

  3 min read
• Press Releases

  Life Sciences IT Market to Capture USD 67.69 Billion by 2034, says Healthcare Experts

  October 15, 2025

   · 

  1 min read
• Press Releases

  Personalized Cancer Vaccine Market Size to Exceed USD 8,501.14 Million by 2034

  October 15, 2025

   · 

  1 min read
• Press Releases

  Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund

  October 15, 2025

   · 

  1 min read
• Press Releases

  PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings

  Expanding ketamine indications, fortifying IP, enabling earlier partnerships, and accelerating FDA pathways - underpinned by PharmaTher’s Digital Health AI division, leveraging the Company’s FDA-approved ketamine ANDA CMC and KetaVault(TM) data advantage.

  October 15, 2025

   · 

  7 min read
• Press Releases

  Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025

  October 15, 2025

   · 

  1 min read